Glaxosmithkline Intellectual Property (NO.4) Limited
Registered as GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.4) LIMITED. Company number 11721880. 6 payment practices reports on file, the latest for the period ending 30 June 2026, filed 22 July 2026.
20days on average to pay
- Within 30 days
- 31 to 60 days
- Over 60 days
In the reporting period from 1 January 2026 to 30 June 2026, Glaxosmithkline Intellectual Property (NO.4) Limited reported that it took an average of 20 days to pay its suppliers' invoices. It paid 75% of invoices within 30 days, 25% in 31 to 60 days and 0% after more than 60 days. It said 0% of invoices were not paid within the agreed terms.
That average is faster than 80% of the 6,220 companies whose latest report covers a period ending since May 2025. A year earlier, in the period to 30 June 2025, the average was 42 days, so it is 22 days faster now.
Average days to pay, report by report
Bars are labelled with the month the period ended. The dashed line marks 30 days.
Every report filed
| Period | Filed | Average days | Within 30 days | 31 to 60 | Over 60 | Not within terms | Source |
|---|---|---|---|---|---|---|---|
| Jan to Jun 2026 | 22 Jul 2026 | 20 | 75% | 25% | 0% | 0% | Report |
| Jul to Dec 2025 | 26 Jan 2026 | 44 | 38% | 12% | 50% | 0% | Report |
| Jan to Jun 2025 | 29 Jul 2025 | 42 | 50% | 0% | 50% | 0% | Report |
| Jul to Dec 2024 | 31 Jan 2025 | 39 | 29% | 43% | 28% | 0% | Report |
| Jan to Jun 2024 | 30 Jul 2024 | 71 | 0% | 0% | 100% | 0% | Report |
| Jul to Dec 2023 | 30 Jan 2024 | 33 | 0% | 100% | 0% | 0% | Report |
Source: the company's filings on Check payment practices. Contains public sector information licensed under the Open Government Licence v3.0. Figures are as filed. We do not change them.